![Medtronic PROTECTA XT DR D314DRG Скачать руководство пользователя страница 177](http://html.mh-extra.com/html/medtronic/protecta-xt-dr-d314drg/protecta-xt-dr-d314drg_clinician-manual_1763148177.webp)
SVT: VT/VF Rx Withheld – The number of episodes initially detected for each
supraventricular tachycardia (SVT) discrimination feature, causing VT/FVT/VF detection
and therapy to be withheld.
Note: Only SVTs with rates in the treated zones are included.
V. Oversensing: VT/VF Rx Withheld – The number of episodes initially detected as
TWave Discrimination or RV Lead Noise Discrimination (ventricular oversensing
discrimination features) for which VT/FVT/VF detection and therapy were withheld.
6.9.3 VT/VF therapy counters
Figure 52. VT/VF therapy counters
The following count data is available for VT/VF therapies:
VT/VF Therapy Summary – The number of pace-terminated tachyarrhythmias,
shock-terminated tachyarrhythmias, total VT/VF shocks, and aborted charges.
VT/VF Therapy Efficacy Since Last Session – The number and types of VF, FVT, and
VT therapies delivered, whether they were successful (if no redetection occurred), and, for
VT and FVT therapies, whether redetected episodes had accelerated (and were redetected
as faster tachyarrhythmias). The 6 listed therapies refer to Rx1 through Rx6 for each episode
type.
Medtronic
PROTECTA™ XT DR D314DRG
Clinician Manual
177
Содержание PROTECTA XT DR D314DRG
Страница 2: ......
Страница 9: ...Index 488 Medtronic PROTECTA XT DR D314DRG Clinician Manual 9 ...
Страница 506: ......
Страница 507: ......